CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common stock
- Shares outstanding
- 15,075,924
- Total 13F shares
- 4,141,182
- Share change
- -534,650
- Total reported value
- $13,791,000
- Price per share
- $3.33
- Number of holders
- 23
- Value change
- -$1,829,588
- Number of buys
- 8
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230770109:
Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARIEL INVESTMENTS, LLC |
13F
|
Company |
7.2%
|
1,084,223
|
$3,936,000 | — | 31 Mar 2020 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
6%
|
907,735
|
$3,295,000 | — | 31 Mar 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
5.7%
|
852,622
|
$3,095,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.1%
|
471,658
|
$1,712,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.6%
|
391,596
|
$1,422,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.2%
|
327,615
|
$1,189,000 | — | 31 Mar 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
183,000
|
$664,000 | — | 31 Mar 2020 | |
| BERKSHIRE ASSET MANAGEMENT LLC/PA |
13F
|
Company |
1.1%
|
164,495
|
$597,000 | — | 31 Mar 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.61%
|
92,643
|
$335,000 | — | 31 Mar 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.35%
|
53,441
|
$194,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
48,610
|
$176,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
24,748
|
$90,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
20,214
|
$74,000 | — | 31 Mar 2020 | |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC |
13F
|
Company |
0.11%
|
16,246
|
$59,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
12,168
|
$44,000 | — | 31 Mar 2020 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.07%
|
10,000
|
$36,000 | — | 31 Mar 2020 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.03%
|
5,198
|
$18,000 | — | 31 Mar 2020 | |
| Oakworth Capital, Inc. |
13F
|
Company |
0.02%
|
3,052
|
$11,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
2,862
|
$10,000 | — | 31 Mar 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.01%
|
1,473
|
$5,000 | — | 31 Mar 2020 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
558
|
$2,000 | — | 31 Mar 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
223
|
$1,000 | — | 31 Mar 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
185
|
$1,000 | — | 31 Mar 2020 |
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q2 2020
As of 30 Jun 2020,
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,141,182 shares.
The largest 10 holders included
DIMENSIONAL FUND ADVISORS LP, ARIEL INVESTMENTS, LLC, Stonepine Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., BRIDGEWAY CAPITAL MANAGEMENT INC, ACADIAN ASSET MANAGEMENT LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
21
Q2 2020 holders
23
Holder diff
2
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.